JILLIAN PORTO: Open Payments
NPI 1225661929 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 8 | $194 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Amgen Inc. | 2 | $52 |
| HARMONY BIOSCIENCES LLC | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Electromed, Inc. | 1 | $18 |
Products named: Ohtuvayre, NUCALA, TEZSPIRE, WAKIX, GLASSIA, AIRSUPRA, SMARTVEST.
Industry payments across CT — which companies pay providers there.
